The causes of brain tumor development are largely unknown. To investigate this question, researchers from University of Basel, Switzerland and University of Freiburg, Germany, used microarray technology to compare the levels of gene expression in the heads of healthy flies and those with brain cancer.
They found significant changes in the expression levels of 321 different genes. These were involved in several different processes including metabolism, cell proliferation, gene transcription and protein translation.
"One fifth of these genes show homology to known mammalian genes involved in cancer formation," write the researchers.
The flies with cancer had mutations in the tumor-suppressor gene brain tumor (brat), which stopped the gene from functioning correctly. Inactivation of the brat gene causes the Drosophila larval brain to overgrow. The majority of larvae do not make it to adulthood - only 15% of them turn into flies. Surviving flies have large brains made up of cancerous tissue, and they normally die young.
If cells from this cancerous tissue are transplanted into a healthy fly, they grow rapidly and spread – forming secondary tumors around the fly's body. The researchers plan to use the information that they have gathered from this experiment to elucidate which of the genes upregulated in these cancer cells are responsible for the cells' metastatic behaviour.
This press release is based on the following article:
Transcriptional signature of an adult brain tumor in Drosophila
Thomas Loop, Ronny Leemans, Urs Stiefel, Leandro Hermida, Boris Egger, Fukang Xie, Michael Primig, Ulrich Certa, Karl-Friedrick Fischbach, Heinrich Reichert, and Frank Hirth
BMC Genomics 2004, 5:24
To be published Friday 16 April, 2004
Upon publication this article will be available free of charge, according to BMC Genomic's Open Access policy at http://www.biomedcentral.com/1471-2164/5/24
For further information about this research please contact Frank Hirth by email at Frank.Hirth@unibas.ch or by phone on 41-61-267-1617.
Alternatively, or for more information about BMC Genomics or Open Access publishing, contact Gemma Bradley by email at press@biomedcentral.com or by phone on 44-207-323-0323
BMC Genomics (http://www.biomedcentral.com/bmcgenomics) is published by BioMed Central (http://www.biomedcentral.com), an independent online publishing house committed to providing Open Access to peer-reviewed biological and medical research. This commitment is based on the view that immediate free access to research and the ability to freely archive and reuse published information is essential to the rapid and efficient communication of science. BioMed Central currently publishes over 100 journals across biology and medicine. In addition to open-access original research, BioMed Central also publishes reviews, commentaries and other non-original-research content. Depending on the policies of the individual journal, this content may be open access or provided only to subscribers.
Journal
BMC Genomics